Cytosorbents
(NASDAQ) CTSO
Cytosorbents Financials at a Glance
Market Cap
$22.75M
Revenue (TTM)
$37.20M
Net Income (TTM)
-$11.85M
EPS (TTM)
-$0.19
P/E Ratio
-1.90
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$0.40
Volume
329,631
Open
$0.47
Price
$0.40
Volume
329,631
Open
$0.47
Previous Close
$0.36
Daily Range
$0.36 - $0.50
52-Week Range
$0.36 - $1.30
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$0.40
Volume
329,631
Open
$0.47
Previous Close
$0.36
Daily Range
$0.36 - $0.50
52-Week Range
$0.36 - $1.30
Estimated Earnings Date
Aug 6, 2026
CTSO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cytosorbents
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
129
CEO
Phillip P. Chan, MD, PhD
Website
cytosorbents.comHeadquarters
Princeton, NJ 08540, US
CTSO Financials
Key Financial Metrics (TTM)
Gross Margin
71.01%
Operating Margin
-36.01%
Net Income Margin
-31.85%
Return on Equity
-165.13%
Return on Capital
-40.67%
Return on Assets
-29.21%
Earnings Yield
-52.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$22.75M
Shares Outstanding
62.84M
Volume
329.63K
Avg. Volume
158.42K
Financials (TTM)
Gross Profit
$26.41M
Operating Income
-$13.40M
EBITDA
-$7.78M
Operating Cash Flow
-$10.07M
Capital Expenditure
-$127.76K
Free Cash Flow
-$10.20M
Cash & ST Invst.
$4.81M
Total Debt
$18.96M
Cytosorbents Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.86M
+1.6%
Gross Profit
$6.13M
-1.3%
Gross Margin
69.16%
N/A
Market Cap
$22.75M
N/A
Market Cap/Employee
$152.68K
N/A
Employees
149
N/A
Net Income
-$5.13M
-246.9%
EBITDA
-$3.90M
-731.6%
Quarterly Fundamentals
Total Cash
$4.81M
-58.5%
Total Debt
$18.96M
-29.7%
Accounts Receivable
$7.15M
-6.8%
Inventory
$4.48M
+48.5%
Long Term Debt
$11.75M
-55.7%
Short Term Debt
$7.21M
+1421.7%
Return on Assets
-29.21%
N/A
Return on Invested Capital
-55.22%
N/A
Free Cash Flow
-$1.17M
+66.6%
Operating Cash Flow
-$1.16M
+66.5%